## **Core Concept**
Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized by inflammation of the synovial joints. The disease involves infiltration of various immune cells into the synovium, leading to joint damage and destruction. Understanding the specific immune cells involved in this process is crucial for managing the disease.

## **Why the Correct Answer is Right**
The correct answer, **Macrophages and T lymphocytes**, are key players in the pathogenesis of rheumatoid arthritis. Macrophages contribute to the inflammatory process by producing pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6. T lymphocytes, particularly Th1 and Th17 cells, also play a significant role by secreting cytokines that promote inflammation and joint destruction. The interaction between these cells and other immune cells in the synovium leads to the characteristic inflammation and joint damage seen in RA.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While plasma cells are present in the synovial infiltrate and contribute to the production of rheumatoid factor and anti-CCP antibodies, they are not considered the most important initial infiltrates in the pathogenesis of RA.
- **Option B:** Neutrophils are abundant in the synovial fluid of RA patients and contribute to inflammation, but they are not the primary infiltrating cells initiating the disease process.
- **Option C:** This option might be considered correct in some contexts, but it lacks specificity regarding the types of lymphocytes involved.
- **Option D:** B lymphocytes play a role in RA, particularly in producing autoantibodies, but they are not considered the most critical infiltrating cells in the disease process.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the **TNF-α inhibitors** (e.g., etanercept, adalimumab) are a class of biologic drugs that target and reduce inflammation by inhibiting tumor necrosis factor-alpha, a cytokine produced by macrophages and other cells. These drugs have revolutionized the treatment of RA by significantly reducing joint inflammation and slowing disease progression.

## **Correct Answer:** . Macrophages and T lymphocytes